cefuroxime has been researched along with Pulmonary Disease, Chronic Obstructive in 4 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with AECOPD and without radiographic evidence of pneumonia were enrolled and randomized to either levofloxacin 500 mg daily or cefuroxime 250 mg twice daily in the mildmoderate exacerbation group, or 500 mg twice daily in the severe exacerbation group, for seven days." | 2.78 | Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease. ( Chung, HS; Han, SK; Kim, DK; Kim, JY; Kim, YW; Lee, CH; Lee, CT; Lee, JH; Lee, SM; Park, GM; Yim, JJ; Yoo, CG; Yoon, HI, 2013) |
| "34 individuals with severe COPD." | 2.70 | Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen. ( Blum, J; Branscombe, JM; Harrow, EM; Oldenburg, FA; Rodgerson, L; Shortall, SP, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yoon, HI | 1 |
| Lee, CH | 1 |
| Kim, DK | 1 |
| Park, GM | 1 |
| Lee, SM | 1 |
| Yim, JJ | 1 |
| Kim, JY | 1 |
| Lee, JH | 1 |
| Lee, CT | 1 |
| Chung, HS | 1 |
| Kim, YW | 1 |
| Han, SK | 1 |
| Yoo, CG | 1 |
| Ruiz-González, A | 1 |
| Giménez, A | 1 |
| Gómez-Arbonés, X | 1 |
| Soler-González, J | 1 |
| Sánchez, V | 1 |
| Falguera, M | 1 |
| Porcel, JM | 1 |
| Petitpretz, P | 1 |
| Choné, C | 1 |
| Trémolières, F | 1 |
| Shortall, SP | 1 |
| Blum, J | 1 |
| Oldenburg, FA | 1 |
| Rodgerson, L | 1 |
| Branscombe, JM | 1 |
| Harrow, EM | 1 |
4 trials available for cefuroxime and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease.
Topics: Aged; Anti-Bacterial Agents; Bacteria; Cefuroxime; Dose-Response Relationship, Drug; Drug Monitoring | 2013 |
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Topics: Amoxicillin; Anti-Infective Agents; Cefuroxime; Clarithromycin; Female; Follow-Up Studies; Forced Ex | 2007 |
Levofloxacin 500 mg once daily versus cefuroxime 250 mg twice daily in patients with acute exacerbations of chronic obstructive bronchitis: clinical efficacy and exacerbation-free interval.
Topics: Aged; Bronchitis, Chronic; Cefuroxime; Female; Heart Failure; Humans; Levofloxacin; Male; Middle Age | 2007 |
Treatment of patients hospitalized for exacerbations of chronic obstructive pulmonary disease: comparison of an oral/metered-dose inhaler regimen and an intravenous/nebulizer regimen.
Topics: Administration, Inhalation; Administration, Oral; Aged; Albuterol; Bronchodilator Agents; Cefuroxime | 2002 |